65°F
weather icon Windy
Filters Reset
1 - 10 of about 12 Results
Content Type
Categories
Authors
Tags
Year
Month
older archives
 
FDA approves updated COVID-19 vaccines for fall

The agency is hoping to blunt any surge in COVID-19 cases or hospitalizations as part of a shift to treating the vaccine like getting a yearly flu shot.

 
Biden, Harris target 10 drugs for Medicare price-lowering plan

The Biden administration is targeting the blood thinner Eliquis, diabetes treatment Jardiance and eight other medications for Medicare’s first-ever drug price negotiations as it seeks to lower medical costs for Americans.

Type 2 diabetes drug could revolutionize weight loss care

Tirzepatide helped people with the disease who were overweight or had obesity lose up to 16% of their body weight over nearly 17 months, officials with Eli Lilly and Co. said.

Judge’s ruling undercuts US health law’s preventive care

U.S. District Judge Reed O’Connor wrote in his opinion that recommendations for preventive care by the U.S. Preventive Services Task Force were “unlawful.”

 
FDA approves over-the-counter Narcan. Here’s what it means

It’s a move that some advocates have long sought as a way to improve access to a life-saving drug, though the exact impact will not be clear immediately.

New COVID-19 origins data point to raccoon dogs in China market

Genetic material collected at a Chinese market near where the first human cases of COVID-19 were identified show raccoon dog DNA comingled with the virus, international experts say.

 
FDA: Two more eyedrop brands recalled due to risks

U.S. health officials are recalling two eyedrop brands due to contamination risks that could lead to vision problems and serious injury.

 
Lilly plans to slash some insulin prices, expand cost cap

Eli Lilly will cut prices for some older insulins later this year and immediately expand a cap on costs insured patients pay to fill prescriptions.